{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:23:59Z","timestamp":1773415439477,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bpg.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T07:15:53Z","timestamp":1491981353000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"Annemiek A.","family":"van der Eijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan D.","family":"Pas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3201\/eid1805.111712","article-title":"Hepatitis E virus infection among solid organ transplant recipients, The Netherlands","volume":"18","author":"Pas","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.bpg.2017.03.006_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"An emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpg.2017.03.006_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2015.11.038","article-title":"Hepatitis E virus genotype 3 infection in a tertiary referral center in The Netherlands: clinical relevance and impact on patient morbidity","volume":"74","author":"Nijskens","year":"2016","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"issue":"Pt 10","key":"10.1016\/j.bpg.2017.03.006_bib5","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.068429-0","article-title":"Consensus proposals for classification of the family Hepeviridae","volume":"95","author":"Smith","year":"2014","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib6","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.10.048","article-title":"Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib7","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JVI.02762-12","article-title":"Genetic variability and the classification of hepatitis E virus","volume":"87","author":"Smith","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.482","article-title":"Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis","volume":"16","author":"Lu","year":"2006","journal-title":"Rev Med Virol"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib9","first-page":"618","article-title":"Analysing complete genome sequence of swine hepatitis E virus (HEV), strain CHN-XJ-SW13 isolated from Xinjiang, China: putative host range, and disease severity determinants in HEV","volume":"11","author":"Fu","year":"2011","journal-title":"Infect Genet Evol Journal Mol Epidemiol Evol Genet Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.bpg.2017.03.006_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.vetmic.2013.01.026","article-title":"Genetic variability of HEV isolates: inconsistencies of current classification","volume":"165","author":"Oliveira-Filho","year":"2013","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virusres.2007.02.002","article-title":"Genetic variability and evolution of hepatitis E virus","volume":"127","author":"Okamoto","year":"2007","journal-title":"Virus Res"},{"issue":"1\u20132","key":"10.1016\/j.bpg.2017.03.006_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.vetmic.2015.04.020","article-title":"Generation of hepatitis E virus-like particles of two new genotypes G5 and G6 and comparison of antigenic properties with those of known genotypes","volume":"178","author":"Li","year":"2015","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jviromet.2007.01.030","article-title":"Increased hepatitis E virus prevalence on Dutch pig farms from 33 to 55% by using appropriate internal quality controls for RT-PCR","volume":"143","author":"Rutjes","year":"2007","journal-title":"J Virol Methods"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib14","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.4315\/0362-028X-70.12.2889","article-title":"Hepatitis E virus RNA in commercial porcine livers in The Netherlands","volume":"70","author":"Bouwknegt","year":"2007","journal-title":"J Food Prot"},{"issue":"31","key":"10.1016\/j.bpg.2017.03.006_bib15","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","article-title":"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012","volume":"18","author":"Slot","year":"2013","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/infdis\/jis688","article-title":"Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates","volume":"207","author":"Wenzel","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib17","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/trf.12733","article-title":"Past and present of hepatitis E in the Netherlands","volume":"54","author":"Hogema","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2009.01.005","article-title":"Indigenous hepatitis E virus infection in England: more common than it seems","volume":"44","author":"Ijaz","year":"2009","journal-title":"J Clin Virol"},{"issue":"10 0 2","key":"10.1016\/j.bpg.2017.03.006_bib19","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/trf.12326","article-title":"An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients","volume":"53","author":"Xu","year":"2013","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.bpg.2017.03.006_bib20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1511.091094","article-title":"Hepatitis E outbreak on cruise ship","volume":"15","author":"Said","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","article-title":"Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy","volume":"14","author":"Peron","year":"2007","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","article-title":"Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation","volume":"122","author":"Versluis","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu032","article-title":"Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve to chronic infections","volume":"209","author":"Abravanel","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.healun.2012.10.008","article-title":"Clinical implications of chronic hepatitis E virus infection in heart transplant recipients","volume":"32","author":"Koning","year":"2013","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jcv.2013.10.010","article-title":"Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients","volume":"58","author":"Pas","year":"2013","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.bpg.2017.03.006_bib29","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood.V96.9.3290","article-title":"Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation","volume":"96","author":"Storek","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib30","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3324\/haematol.2011.047696","article-title":"Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Wils","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2004.04.001","article-title":"Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement","volume":"19","author":"Wils","year":"2005","journal-title":"Blood Rev"},{"issue":"10","key":"10.1016\/j.bpg.2017.03.006_bib32","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","article-title":"The role of hepatitis E virus testing in drug-induced liver injury","volume":"26","author":"Dalton","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib33","first-page":"1","article-title":"Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature","volume":"4","author":"Bazerbachi","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneurol.2015.234","article-title":"Hepatitis E virus and neurological injury","volume":"12","author":"Dalton","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/CMR.00062-13","article-title":"Host immune status and response to hepatitis E virus infection","volume":"27","author":"Krain","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3201\/eid1702.100856","article-title":"Hepatitis E virus and neurologic disorders","volume":"17","author":"Kamar","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1600-6143.2010.03068.x","article-title":"Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis","volume":"10","author":"Kamar","year":"2010","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000000112","article-title":"Neuralgic amyotrophy and hepatitis E virus infection","volume":"82","author":"van Eijk","year":"2014","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bpg.2017.03.006_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.bpg.2017.03.006_bib41","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","article-title":"Guillain-Barre and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan","volume":"37","author":"Fukae","year":"2016","journal-title":"Neurol Sci"},{"issue":"7","key":"10.1016\/j.bpg.2017.03.006_bib42","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jvh.12515","article-title":"Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells","volume":"23","author":"Drave","year":"2016","journal-title":"J Viral Hepat"},{"issue":"11\u201312","key":"10.1016\/j.bpg.2017.03.006_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/apt.12986","article-title":"Extra-hepatic manifestations of autochthonous hepatitis E infection","volume":"40","author":"Woolson","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","article-title":"Hepatitis E virus and the kidney in solid-organ transplant patients","volume":"93","author":"Kamar","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00005176-200502000-00027","article-title":"Hepatitis E virus infection with nonimmune hemolytic anemia","volume":"40","author":"Zamvar","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1155\/2003\/913679","article-title":"Case report: acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency","volume":"14","author":"Monga","year":"2003","journal-title":"Can J Infect Dis"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MPH.0b013e31818c00db","article-title":"Childhood hepatitis E infection complicated by acute immune thrombocytopenia","volume":"31","author":"Thapa","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MPH.0b013e3181984dab","article-title":"Hepatitis E virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase deficiency","volume":"31","author":"Thapa","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib49","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1572-0241.2002.05740.x","article-title":"Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E","volume":"97","author":"Abid","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0049475514559959","article-title":"Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency","volume":"45","author":"Tomar","year":"2015","journal-title":"Trop Doct"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12664-012-0226-9","article-title":"Increased morbidity in acute viral hepatitis with glucose-6-phosphate dehydrogenase deficiency","volume":"32","author":"Jain","year":"2013","journal-title":"Indian J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib52","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jhep.2012.05.010","article-title":"Hepatitis E virus-induced severe myositis","volume":"57","author":"Del Bello","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2017.03.006_bib53","first-page":"458056","article-title":"Acute viral hepatitis e is associated with the development of myocarditis","volume":"2015","author":"Premkumar","year":"2015","journal-title":"Case Rep Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib54","doi-asserted-by":"crossref","DOI":"10.4172\/2161-069X.1000386","article-title":"Acute myopericarditis due to hepatitis E virus infection: the first reported case in the western hemisphere","volume":"6","author":"Dougherty","year":"2016","journal-title":"J Gastrointest Dig Syst"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1473-3099(14)70823-0","article-title":"HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E.","volume":"14","author":"Pischke","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.ajkd.2015.10.022","article-title":"Hepatitis E virus-induced cryoglobulinemic glomerulonephritis in a nonimmunocompromised person","volume":"67","author":"Guinault","year":"2016","journal-title":"Am J kidney Dis \u2013 Off J Natl Kidney Found"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tid.12353","article-title":"Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin","volume":"17","author":"Del Bello","year":"2015","journal-title":"Transpl Infect Dis \u2013 Off J Transplant Soc"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3851\/IMP2317","article-title":"Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report","volume":"17","author":"Goyal","year":"2012","journal-title":"Antivir Ther"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","article-title":"Treatment of severe acute hepatitis E by ribavirin","volume":"52","author":"Gerolami","year":"2011","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib61","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2011.01.009","article-title":"Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?","volume":"54","author":"Peron","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/liv.12911","article-title":"Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study","volume":"36","author":"Peron","year":"2016","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib63","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/apt.13309","article-title":"Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK\/French study","volume":"42","author":"Blasco-Perrin","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.bpg.2017.03.006_bib64","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1053\/j.gastro.2014.02.036","article-title":"Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus","volume":"146","author":"Wang","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib66","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bpg.2017.03.006_bib67","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/QCO.0000000000000316","article-title":"Treatment of hepatitis E virus","volume":"29","author":"Dalton","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciu742","article-title":"Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse","volume":"60","author":"Abravanel","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib69","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir inhibits hepatitis e virus replication in vitro and results in an additive effect when combined with ribavirin","volume":"150","author":"Dao Thi","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib70","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jhep.2016.09.014","article-title":"Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection","volume":"66","author":"van der Valk","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.gastro.2016.05.060","article-title":"Sofosbuvir and daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV\/HCV co-infected liver transplant recipient","volume":"152","author":"Donnelly","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2017.03.006_bib72","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gutjnl-2016-312040","article-title":"Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing","volume":"65","author":"Gouttenoire","year":"2016","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.bpg.2017.03.006_bib73","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib74","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/AAC.02496-15","article-title":"Mutation in the hepatitis e virus polymerase and outcome of ribavirin therapy","volume":"60","author":"Lhomme","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib75","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib76","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients","volume":"8","author":"Kamar","year":"2008","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.bpg.2017.03.006_bib77","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3201\/eid1712.110371","article-title":"Hepatitis E virus antibodies in blood donors, France","volume":"17","author":"Mansuy","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"10.1016\/j.bpg.2017.03.006_bib78","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.19.21127","article-title":"Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011","volume":"20","author":"Mansuy","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.bpg.2017.03.006_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcv.2015.06.103","article-title":"Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France","volume":"70","author":"Izopet","year":"2015","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.bpg.2017.03.006_bib80","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.27244","article-title":"Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996\u20132011","volume":"60","author":"Wenzel","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib81","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1128\/JCM.01119-12","article-title":"Novel approach for detection of hepatitis E virus infection in German blood donors","volume":"50","author":"Vollmer","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","article-title":"Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States","volume":"103","author":"Baylis","year":"2012","journal-title":"Vox Sang"},{"issue":"8848","key":"10.1016\/j.bpg.2017.03.006_bib83","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0140-6736(93)90599-C","article-title":"Hepatitis E in The Netherlands: imported and endemic","volume":"341","author":"Zaaijer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2017.03.006_bib84","article-title":"No artifact, hepatitis E is emerging","author":"Zaaijer","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bpg.2017.03.006_bib85","doi-asserted-by":"crossref","first-page":"e110837","DOI":"10.1371\/journal.pone.0110837","article-title":"Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005\u20132006","volume":"9","author":"Jia","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/JCM.01466-09","article-title":"Prevalence of hepatitis E virus in Chinese blood donors","volume":"48","author":"Guo","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<230::AID-JMV12>3.0.CO;2-G","article-title":"A community prevalence study of antibodies to hepatitis A and E in inner-city London","volume":"49","author":"Bernal","year":"1996","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib88","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1423-0410.2011.01554.x","article-title":"Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England","volume":"102","author":"Ijaz","year":"2012","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib89","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1423-0410.2010.01412.x","article-title":"Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?","volume":"100","author":"Beale","year":"2011","journal-title":"Vox Sang"},{"issue":"9956","key":"10.1016\/j.bpg.2017.03.006_bib90","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bpg.2017.03.006_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00365540500321470","article-title":"Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls","volume":"38","author":"Olsen","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.bpg.2017.03.006_bib92","doi-asserted-by":"crossref","first-page":"e0119576","DOI":"10.1371\/journal.pone.0119576","article-title":"Seroprevalence and incidence of hepatitis E in blood donors in upper Austria","volume":"10","author":"Fischer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2017.03.006_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12056","article-title":"Hepatitis E virus in Scottish blood donors","author":"Cleland","year":"2013","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib94","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12929","article-title":"Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain)","volume":"55","author":"Sauleda","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.bpg.2017.03.006_bib95","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/trf.13355","article-title":"Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors","volume":"56","author":"Stramer","year":"2016","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.bpg.2017.03.006_bib96","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3201\/eid2011.140412","article-title":"Hepatitis E virus and implications for blood supply safety, Australia","volume":"20","author":"Shrestha","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.bpg.2017.03.006_bib97","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1440-1746.2007.04894.x","article-title":"Hepatitis E in new zealand","volume":"22","author":"Dalton","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2017.03.006_bib98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jmv.21656","article-title":"A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries","volume":"82","author":"Bendall","year":"2010","journal-title":"J Med Virol"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691817300276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691817300276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T10:24:53Z","timestamp":1601893493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691817300276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1521691817300276"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2017.03.006","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}